IL-33 Promotes ST2-Dependent Fibroblast Maturation Via P38 and TGF-β in a Mouse Model of Epidural Fibrosis
Overview
Affiliations
Background: Recent evidence suggests that IL-33, a novel member of the IL-1β family, is involved in organ fibrosis. However, the roles of IL-33 and its receptor ST2 in epidural fibrosis post spine operation remain elusive.
Methods: A mouse model of epidural fibrosis was established after laminectomy. IL-33 in the wound tissues post laminectomy was measured with Western blotting, ELISA and immunoflurosence imaging. The fibroblast cell line NIH-3T3 and primary fibroblasts were treated with IL-33 and the mechanisms of maturation of fibroblasts into myofibroblasts were analyzed. To explore roles of IL-33 and its receptor ST2 in vivo, IL-33 knockout (KO) and ST2 KO mice were employed to construct the model of laminectomy. The epidural fibrosis was evaluated using H&E and Masson staining, western-blotting, ELISA and immunohistochemistry.
Results: As demonstrated in western blotting and ELISA, IL-33 was increased in epidural wound tissues post laminectomy. The immunoflurosence imaging revealed that endothelial cells (CD31) and fibroblasts (α-SAM) were major producers of IL-33 in the epidural wound tissues. In vitro, IL-33 promoted fibroblast maturation, which was blocked by ST2 neutralization antibody, suggesting that IL-33-promoted-fibroblasts maturation was ST2 dependent. Further, IL-33/ST2 activated MAPK p38 and TGF-β pathways. Either p38 inhibitor or TGF-β inhibitor decreased fibronectin and α-SAM production from IL-33-treated fibroblasts, suggesting that p38 and TGF-β were involved with IL-33/ST2 signal pathways in the fibroblasts maturation. In vivo, IL-33 KO or ST2 KO decreased fibronectin, α-SMA and collagen deposition in the wound tissues of mice that underwent spine surgery. In addition, TGF-β1 was decreased in IL-33 KO or ST2 KO epidural wound tissues.
Conclusion: In summary, IL-33/ST2 promoted fibroblast differentiation into myofibroblasts via MAPK p38 and TGF-β in a mouse model of epidural fibrosis after laminectomy.
Wang Y, Ding H, Bai R, Li Q, Ren B, Lin P Stem Cell Res Ther. 2025; 16(1):80.
PMID: 39984984 PMC: 11846291. DOI: 10.1186/s13287-025-04203-x.
Uemura K, Katayama K, Nishioka T, Watanabe H, Yamada G, Inoue N Int J Mol Sci. 2025; 26(3).
PMID: 39941140 PMC: 11818732. DOI: 10.3390/ijms26031371.
Ganesh V, Kancherla Y, Igram C, Pugely A, Salem A, Shin K Spine J. 2023; 23(10):1471-1484.
PMID: 37187251 PMC: 10538436. DOI: 10.1016/j.spinee.2023.05.007.
Luzina I, Lockatell V, Courneya J, Mei Z, Fishelevich R, Kopach P Cell Immunol. 2023; 383:104657.
PMID: 36603504 PMC: 9909894. DOI: 10.1016/j.cellimm.2022.104657.
Cao Y, Chen H, Sun Y, Fan Z, Cheng H Bioengineered. 2022; 13(4):9973-9986.
PMID: 35412948 PMC: 9161887. DOI: 10.1080/21655979.2022.2062530.